Skip Navigation LinksHome > About the Journal

About the Journal

International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes.

A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.

Publication & Editorial Staff Contacts


Publisher
Phil Daly
Phil.Daly@wolterskluwer.com

Production Editor
Kavi Ganeshananthan
Kavi.Ganeshananthan@wolterskluwer.com

Marketing
Jon Muir
Jon.Muir@wolterskluwer.com

Translation, Rights & Licensing
Silvia Serra
translationrights@wolterskluwer.com

LWW Business Offices
250 Waterloo Road
London SE1 8RD, UK
Phone: +44-(0)20 7981 0600
www.lww.com

International Advertising Representative
The Point of Difference
4 Chase Avenue
London SW20 8LU, UK
Phone: +44-(0)20 8542 3200
Fax: +44-(0)20 8543 3810
pointofdiff@btinternet.com

Editor-in-Chief
Professor Stuart A Montgomery
International Clinical Psychopharmacology
P.O. Box 8751
London W13 8WH
UK
ICP@samontgomery.co.uk